ALK and lung adenocarcinoma: Lung adenocarcinoma (cT3N0M1c, AJCC 8th edition) with synchronous brain and pulmonary metastases molecularly characterized as epidermal growth factor receptor- and anaplastic lymphoma kinase-negative.